Role and Scope of Ethnomedical Plants in the Development of Antivirals
Pharmacologyonline 3: 64-72 (2006)
Newsletter
ROLE AND SCOPE OF ETHNOMEDICAL PLANTS IN THE DEVELOPMENT OF ANTIVIRALS
Debprasad Chattopadhyay
ICMR Virus Unit, ID & BG Hospital, GB 4, First floor, 57 Dr. Suresh C Banerjee Road, Beliaghata, Kolkata 700 010, India.
Summary Ethnomedicinal plants have been used as source of drugs for almost all diseases, but none are used against viruses probably because there are a very few specific viral targets for natural molecules to interact. Most of the available antiviral drugs often lead to side effects, viral resistance, recurrence and latency. A wide range of ethnomedicinal plants showed strong antiviral activities either by inhibiting replication, or genome synthesis of many viruses. Hence, development of new antivirals from natural source is an alternate approach. This review will discuss some of the promising antivirals of ethnomedicinal plants with proven in vitro and some documented in vivo activities. Keywords: Ethnomedicines; Antivirals, HSV; HIV.
People of all continents have long used poultices and infusions of indigenous plants like cedar wood and cypress oil, juice of licorice, myrrh and poppy for the treatment of coughs and colds to parasitic infections and inflammation1. The clinical virologists are looking into the antiviral plant extracts as (i) the effective life span of antiviral drug is limited; (ii) many viral diseases are intractable to most of the orthodox antivirals, (iii) development of viral resistance, latency and recurrence, and (iv) rapid spread of emerging and reemerging viral diseases like HIV/AIDS, SARS etc. All these spurred intensive investigation into the ethnomedicines, especially for people unable to afford expensive antivirals, and the impressive array of knowledge and wisdom of indigenous people about their generation old medicaments for the development of new or complementary antivirals. 64
Pharmacologyonline 3: 64-72 (2006)
Newsletter
Chattopadhyay
Viral
Newsletter
ROLE AND SCOPE OF ETHNOMEDICAL PLANTS IN THE DEVELOPMENT OF ANTIVIRALS
Debprasad Chattopadhyay
ICMR Virus Unit, ID & BG Hospital, GB 4, First floor, 57 Dr. Suresh C Banerjee Road, Beliaghata, Kolkata 700 010, India.
Summary Ethnomedicinal plants have been used as source of drugs for almost all diseases, but none are used against viruses probably because there are a very few specific viral targets for natural molecules to interact. Most of the available antiviral drugs often lead to side effects, viral resistance, recurrence and latency. A wide range of ethnomedicinal plants showed strong antiviral activities either by inhibiting replication, or genome synthesis of many viruses. Hence, development of new antivirals from natural source is an alternate approach. This review will discuss some of the promising antivirals of ethnomedicinal plants with proven in vitro and some documented in vivo activities. Keywords: Ethnomedicines; Antivirals, HSV; HIV.
People of all continents have long used poultices and infusions of indigenous plants like cedar wood and cypress oil, juice of licorice, myrrh and poppy for the treatment of coughs and colds to parasitic infections and inflammation1. The clinical virologists are looking into the antiviral plant extracts as (i) the effective life span of antiviral drug is limited; (ii) many viral diseases are intractable to most of the orthodox antivirals, (iii) development of viral resistance, latency and recurrence, and (iv) rapid spread of emerging and reemerging viral diseases like HIV/AIDS, SARS etc. All these spurred intensive investigation into the ethnomedicines, especially for people unable to afford expensive antivirals, and the impressive array of knowledge and wisdom of indigenous people about their generation old medicaments for the development of new or complementary antivirals. 64
Pharmacologyonline 3: 64-72 (2006)
Newsletter
Chattopadhyay
Viral
References: 1. Newman DJ, Cragg GM, Snader KM. The influence of natural product upon drug discovery. Nat Prod Rep, 2000: 17: 215-234. 2. Wagner EK, Hewlett M. J. Basic Virology. Blackwell Science, Malden, MA, USA, 1999. 3. Hegde VR, Pu H, Patel M. et al. Two antiviral compounds from the plant Stylogne cauliflora as inhibitors of HCV NS3 protease. Bioorg Med Chem Lett, 2003: 13: 2925-2928. 4. Li Y, Ooi LS, Wang H, But PP, Ooi VE. Antiviral activities of medicinal herbs traditionally used in Southern Mainland China. Phytother Res 2004: 18: 718-722. 5. Khan MT, Ather A, Thompson KD, Gambari R. Extracts and molecules from medicinal plants against herpes simplex viruses. Antivir Res, 2005: 67: 107-119. 6. Cheng HY, Lin TC, Yang CM, Shieh DE, Lin CC. In vitro anti-HSV-2 activity and mechanism of action of proanthocyanidin A-1 from Vaccinium vitis-idaea. J Sci Food Agricul, 2005: 85: 10-15. 7. Buckwold VE, Wilson RJ, Nalca A. et al. Antiviral activity of Hop constituents against a series of DNA and RNA viruses. Antiviral Res, 2004: 61: 57-62. 70 Pharmacologyonline 3: 64-72 (2006) Newsletter Chattopadhyay 8. Cos P, Maes L, Vanden Berghe D, Hermans N, Pieters L, Vlietinck A. Plant substances as anti-HIV agents selected according to their putative mechanism of action. J Nat Prod, 2004: 67: 284-293. 9. Yu D, Suzuki M, Xie L, Morris-Natschke SL, Lee KH. Recent progress in the development of coumarin derivatives as potent anti-HIV agents. Med Res Rev, 2003: 23: 322-345. 10. Yamaguchi K, Honda M, Ikigai H, Hara Y, Shimamura T. Inhibitory effects of (-)epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1. Antivral Res, 2002: 53: 19-34. 11. Arthan D, Svasti J, Kittakoop P, Pittayakhachonwut D, Tanticharoen M, Thebtaranonth Y. Antiviral isoflavonoid sulfate and steroidal glycosides from Solanum torvum. Phytochem, 2002: 59: 459-463. 12. Robin V, Irurzun A, Amoros M, Boustie J, Carrasco L. Antipoliovirus flavonoids from Psiadia dentata.Antivir Chem Chemother, 2001: 12: 283-291. 13. Likhitwitayawuid K, Sritularak B, Benchanak K, Lipipun V, Mathew J, Schinazi RF. Phenolics with antiviral activity of Millettia erythrocalyx and Artocarpus lakoocha. Nat Prod Res, 2005: 19: 177-182. 14. Tai MC, Tsang SY, Chang LY, Xue H. Therapeutic potential of wogonin: a naturally occurring flavonoid. CNS Drug Review, 2005: 11: 141-150. 15. Chen C-N, Lin Coney PC, Huang KK. et al. Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3′-digallate (TF3). Evid Based Complement Alternat Med, 2005: 2: 209-215. 16. Jassim SA, Naji MA. Novel antiviral agents: a medicinal plant perspective. J Appl Microbiol, 2003: 95: 412-427. 17. Chiang LC, Ng LT, Cheng PW, Chiang W, Lin CC. Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clin Exp Pharmacol Physiol., 2005: 32: 811-816. 18. Cheng HY, Yang CM, Lin TC, Shieh DE, Lin CC. ent-Epiafzelechin-(4alpha-->8)epiafzelechin extracted from Cassia javanica inhibits HSV-2 replication. J Med Microbiol, 2006: 55: 201-206. 19. Farag RS, Shalaby AS, El-Baroty GA, Ibrahim NA, Ali, MA, Hassan EM. Chemical and biological evaluation of the essential oils of different Melaleuca species. Phytother Res, 2004: 18: 30-35. 20. Cheng HY, Lin TC, Yang CM, Wang KC, Lin LT, Lin CC. Putranjivain A from Euphorbia jolkini inhibits both virus entry and late stage replication of herpes simplex virus type 2 in vitro. J Antimicrob Chemother, 2004: 53: 577-583. 21. Yogeeswari P, Sriram D. Betulinic acid and its derivatives: a review on their biological properties. Curr Med Chem, 2005: 12(6): 657-666. 22. Garcia CC, Talarico L, Almeida N, Colombres S, Duschatzky C, Damonte EB. Virucidal activity of essential oils from aromatic plants of San Luis, Argentina. Phytother Res, 2003: 17: 1073-1075. 71 Pharmacologyonline 3: 64-72 (2006) Newsletter Chattopadhyay 23. Sakurai N, Wu JH, Sashida Y. et al. Anti-AIDS agents. Part 57: Actein, an antiHIV principle from the rhizome of Cimicifuga racemosa, and the anti-HIV activity of related saponins. Bioorg Med Chem Lett, 2004: 14: 1329-1332. 24. Richter S, Parolin C, Palumbo M, Palu G. Antiviral properties of quinone-based drugs. Curr Drug Targets Infect Disord, 2004: 4: 111-116. 25. Rajbhandari M, Wegner U, Schopke T, Lindequist U, Mentel R. Inhibitory effect of Bergenia ligulata on influenza virus A. Die Pharmaz, 2003: 58: 268-271. 26. Notka F, Meier G.R, Wagner R. Inhibition of wild-type HIV and reverse transcriptase inhibitor-resistant variants by Phyllanthus amarus. Antivir Res, 2003: 58: 175-186. 27. Liu S, Jiang S, Wu Z, Lv L, Zhang J, Zhu Z, Wu S. Identification of inhibitors of the HIV-1 gp41 six-helix bundle formation from extracts of Chinese herbs Prunella vulgaris and Rhizoma cibotte. Life Sci, 2002: 71: 1779-1791. 28. Kuo YH, Li SY, Huang RL, Wu MD, Huang HC, Lee KH. Schizarin B, C, D and E, four new lignans from Kadsura matsudai and their antihepatitis activities. J Nat Prod, 2001: 64: 487-490. 29. Chattopadhyay D, Naik TN. Antivirals of Ethnomedicinal Origin:Structure-activity Relationship and Scope. Mini Rev Med Chem, 2006 (in press). 30. Ovenden SP, Yu J, Wan SS. et al. Globoidnan A: a lignan from Eucalyptus globoidea inhibits HIV integrase. Phytochem , 2004: 65: 3255-3259. 31. Chattopadhyay D, Arunachalam G, Mandal AB, Bhattacharya SK. Dose dependent therapeutic antiinfectives from ethnomedicines of Bay Islands. Chemother, 2006: 52: 151-157. 32. Olila D, Olwa-Odyek A, Opuda-Asibo J. Screening of Zanthoxylum chalybeum and Warburgia ugandensis for activity against measles virus (Swartz and Edmonston strains) in vitro. J African Health Sci, 2002: 2: 2-10. 33. Serkedjieva J, Velcheva M. In vitro anti-influenza virus activity of the pavine alkaloid (-)-thalimonine isolated from Thalictrum simplex L. Antivir Chem Chemother, 2003: 14: 75-80. 34. Szlavik L, Gyuris A, Minarovits J, Forgo P, Molnar J, Hohmann J. Alkaloids from Leucojum vernum and antiretroviral activity of Amaryllidaceae alkaloids.Planta Med, 2004: 70: 871-873. 35. Wang JH, Nie HL, Huang H, Tam SC, Zheng YT. Independency of anti-HIV-1 activity from ribosome-inactivating activity of trichosanthin. Biochem Biophys Res Commun, 2003: 302: 89-94. 36. Thompson KD, Dragar C. Antiviral activity of Undaria pinnatifida against herpes simplex virus. Phytother Res, 2004: 18: 551-555. 72